E. L. Voorn et al.
patients with LGMD2I. Neurology 2007; 68: 59–61.
32. Westerberg E, Molin CJ, Lindblad I, Emtner M, Punga AR.
Physical exercise in myasthenia gravis is safe and improves
neuromuscular parameters and physical performance-
based measures: a pilot study. Muscle Nerve 2017; 56:
207–214.
33. Rapin A, Etosse A, Tambosco L, Nicomette J, Percebois-
Macadre L, Mouret P, et al. Aerobic capacities and exercise
tolerance in neuromuscular diseases: a descriptive study.
Ann Phys Rehabil Med 2013; 56: 420–433.
34. Voorn EL, Gerrits KH, Koopman FS, Nollet F, Beelen A. De-
termining the anaerobic threshold in postpolio syndrome:
comparison with current guidelines for training intensity
prescription. Arch Phys Med Rehabil 2014; 95: 935–940.
35. Feingold B, Mahle WT, Auerbach S, Clemens P, Dome-
nighetti AA, Jefferies JL, et al. Management of cardiac
involvement associated with neuromuscular diseases: a
scientific statement from the American Heart Association.
Circulation 2017: 136: e200–e231.
524
www.medicaljournals.se/jrm
36. Cup EH, Pieterse AJ, Hendricks HT, Van Engelen BG, Oos-
tendorp RA, Van der Wilt GJ. Implementation of multidisci-
plinary advice to allied health care professionals regarding
the management of their patients with neuromuscular
diseases. Disabil Rehabil 2011; 33: 787–795.
37. Anens E, Emtner M, Hellström K. Exploratory study of phy-
sical activity in persons with Charcot-Marie-Tooth disease.
Arch Phys Med Rehabil 2015; 96: 260–268.
38. Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG,
Bleijenberg G. The development of a model of fatigue in
neuromuscular disorders: a longitudinal study. J Psycho-
som Res 2007; 62: 571–579.
39. Voet N, Bleijenberg G, Hendriks J, de Groot I, Padberg G,
van Engelen B, et al. Both aerobic exercise and cognitive-
behavioral therapy reduce chronic fatigue in FSHD An RCT.
Neurology 2014; 83: 1914–1922.
40. Bloem BR, Munneke M. Revolutionising management of
chronic disease: the ParkinsonNet approach. BMJ 2014;
348: g1838.